Additionally, immunofluorescence analysis of breast tumours revealed that BHS synergized with paclitaxel to significantly decrease the expression of TSG101 and CXCL1, indicating that paclitaxel‐induced EV‐Apo biogenesis and CXCL1 secretion were suppressed (Figure 10f). Here, CXCL1 is linked to breast neoplasm.